Arkolith/Insider Trading/ORIC/Form 4

Chacko Jacob

PRESIDENT AND CEO, DirectorOric Pharmaceuticals, Inc. (ORIC) · full profile →Form 4 · filed Oct 2, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 1, 2025Sell(S)53K$12.05$639K569K
Sep 30, 2025Sell(S)35K$12.01$415K622K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001608936-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML